{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:39:19Z","timestamp":1788471559112,"version":"build-2803163510"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"publisher","award":["FUR 2020"],"award-info":[{"award-number":["FUR 2020"]}],"id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10014-021-00422-1","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:03:39Z","timestamp":1641427419000},"page":"179-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Timing of H3K27me3 loss in secondary anaplastic meningiomas"],"prefix":"10.1007","volume":"39","author":[{"given":"Serena","family":"Ammendola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-1920","authenticated-orcid":false,"given":"Valeria","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"422_CR1","volume-title":"WHO classification of tumors of the central nervous system","author":"DN Louis","year":"2016","unstructured":"Louis DN, Ohgaki H, Wisteler OD, Cavenee WK, Ellison DW, Figarella-Branger D et al (2016) WHO classification of tumors of the central nervous system. Iarc, Lyon"},{"key":"422_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab150","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O, Karimi S, Dalcourt T, Ijad N et al (2021) Loss of H3k27me3 in meningiomas. Neuro Oncol 23:1282\u20131291","journal-title":"Neuro Oncol"},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R et al (2018) Loss of histone H3k27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 135:955\u2013963","journal-title":"Acta Neuropathol."},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noaa303","volume":"23","author":"F Behling","year":"2021","unstructured":"Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F et al (2021) H3k27me3 loss indicates an increased risk of recurrence in the Tubingen meningioma cohort. Neuro Oncol 23:1273\u20131281","journal-title":"Neuro Oncol"},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte G, Peyre M, Pouget C, Cazals-Hatem D, Polivka M, Rech F et al (2020) Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study. J Neuropathol Exp Neurol 79:754\u2013762","journal-title":"J Neuropathol Exp Neurol"},{"key":"422_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03134-1","author":"S Ammendola","year":"2021","unstructured":"Ammendola S, Caldonazzi N, Simbolo M, Piredda ML, Brunelli M, Poliani PL et al (2021) H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-021-03134-1","journal-title":"Virchows Arch"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/1535-7163.MCT-17-1053","volume":"17","author":"BH Rath","year":"2018","unstructured":"Rath BH, Waung I, Camphausen K, Tofilon PJ (2018) Inhibition of the histone H3K27 demethylase UTX enhances tumor cell radiosensitivity. Mol Cancer Ther 17:1070\u20131078","journal-title":"Mol Cancer Ther"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-021-00422-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T06:38:39Z","timestamp":1654670319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-021-00422-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1007\/s10014-021-00422-1","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}